Medical/Pharmaceuticals

Datasea Announces Strategic Partnership with Sales and Marketing Firm for the Launch of Intelligent Acoustic Skin Repair Robot

BEIJING, Aug. 29, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology corporation engaged in converging and innovative business segment for intelligent acoustics technology inChina today announced that Shuhai Information Technology Co., Ltd. ("Shuh...

2023-08-29 21:57 1876

Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC

HONG KONG, Aug. 29, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", 9926. HK) announced completion of patient enrollment in a head-to-head study of ivonescimab (AK112, PD-1/VEGF bispecific antibody) compared with pembrolizumab as first-line treatment for patients with PD-L1 positive (PD-L1 TPS≥1%) loca...

2023-08-29 20:00 1364

Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok

DEPOK, Indonesia, Aug. 29, 2023 /PRNewswire/ -- Bayer, a global Life Science company in health and nutrition, is taking an active role in addressing the stunting problem inIndonesia. Coinciding with Bayer's 66th year in Indonesia, Bayer launched the CETING (Prevent Stunting) program for the commu...

2023-08-29 13:53 2049

OTC Hearing Aids Ceretone Bags over $300,000 on Indiegogo, Prepares for Official Sale

ONTARIO, Calif., Aug. 29, 2023 /PRNewswire/ -- Ceretone , a brand under Audicon and a pioneer in the field of Over-the-Counter (OTC) hearing aids, is thrilled to announce the success of its Core One launch campaign on Indiegogo. T...

2023-08-29 09:51 2010

Kelun-Biotech Announces Interim Results for 2023: Global Strategic Partnership and Rich Pipeline Boost Significant Revenue Growth in the First Half of the Year

CHENGDU, China, Aug. 28, 2023 /PRNewswire/ -- Today, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK), an innovative biopharmaceutical company focusing on the R&D, manufacturing, commercialization, and international cooperation of biotechnology drugs and innovat...

2023-08-28 22:56 3982

Global Times: GT on the spot: An unforgettable record of PLA naval hospital ship's weeklong visit to Solomon Islands

BEIJING, Aug. 28, 2023 /PRNewswire/ -- With groups of people waving goodbye, China's naval hospital ship the Ark Peace sailed from Honiara Harbor on Saturday morning after it successfully concluded its weeklong visit and dispensing medical services to theSolomon Islands. Similar to its arrival, ...

2023-08-28 21:21 1806

Navigating the Future of Neurosurgery: Brain Navi demonstrates NaoTrac and KrystoLens at CNS 2023 & EANS 2023

HSINCHU, Aug. 28, 2023 /PRNewswire/ -- Brain Navi announced today the demonstration of NaoTrac, a neurosurgical navigation robot and KrystoLens, a single-use neuro-endoscope at CNS 2023 inWashington D.C. and EANS 2023 in Barcelona, respectively.

2023-08-28 21:00 1812

ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference

SEATTLE, Aug. 28, 2023 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-drug conjugate therapeutics for cancer, announced that management will be participating in one-on-one meetings at the Morgan Stanley 21st Annual Global Healthca...

2023-08-28 20:00 1271

Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines

The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject® (ferric carboxymaltose), for the management of iron deficiency in patients with HF. Phase IV HEART-FI...

2023-08-28 19:00 2263

3B Scientific acquires iNNOGING Medical

HAMBURG, Germany, Aug. 28, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today that it has reached an agreement to acquire iNNOGING Medical. iNNOGING Medical has developed the pione...

2023-08-28 17:13 2222

Harbour BioMed Announces 2023 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

2023-08-28 17:08 2466

Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Harbour BioMed (the"Company", HKEX: 02142) announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application to commence clinical trials of its first antib...

2023-08-28 16:30 1502

Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan

HANGZHOU, China, Aug. 27, 2023 /PRNewswire/ -- On August 23rd, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") released its financial results for the first half of 2023. The Company's revenue reached230 million yuan, repr...

2023-08-28 11:42 2266

Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress

TAIZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Innovative vaccine company Recbio (02179.HK) announced its latest progress and interim results for 2023. During the reporting period, the company always adhered to the mission of " Protect Human Health With Best-In-Class Vaccines", rapidly promoted pr...

2023-08-28 11:08 3022

26th World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) - Obesity, bariatric surgery 'cuts' the risk of cancer: -25%

NAPLES, Italy, Aug. 28, 2023 /PRNewswire/ -- Losing weight with bariatric surgery can have a major impact on the risk of developing cancer. A study conducted by theUniversity of Utah, Salt Lake City (USA), published in Obesity, has shown that patients with severe obesity who undergo surgery have ...

2023-08-28 08:00 1669

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

.. ST to partner with Dutch biotech company Treeway BV .. First CNS therapy in ST therapeutic portfolio SINGAPORE, Aug. 27, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner withNetherlands based biotechnology company Treeway BV to...

2023-08-28 04:00 1646

First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial

Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...

2023-08-25 20:58 2726

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA

HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that the National Center for Drug Evaluatio...

2023-08-25 20:00 2251

Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline

SHANGHAI and HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its interim results for the six-months endedJune 30, 2023, and provided updates on multiple milestones achieved since the beginning of 2023. Dr. Jay Mei, Antengene's F...

2023-08-25 19:37 2370

Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth

SHANGHAI, Aug. 25, 2023 /PRNewswire/ -- Henlius (2696.HK) announced its 2023 interim results. In the first half of 2023, Henlius reported a boost in operating profits ofRMB240.0 million and revenues of RMB2.5005 billion, up by 93.9% YoY, driven by growth in core oncology products. HANQUYOU (trast...

2023-08-25 19:26 5642
1 ... 160161162163164165166 ... 614